SR-4835

Ask supplier a question | View on supplier's website

SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors.

Supplier	Selleck Chemicals
Product #	S8894
Sku #	S8894-25mg
Pricing	25mg, $670.00

Feedback